Fritextsökning
Artiklar per år
Innehållstyper
-
She creates pharmaceuticals on a 3D printer
The correct dosage for each individual, regardless of whether the pharmaceutical is for a seriously ill child or a frail elderly person, is the mission of a well-advanced project with 3D-printed drugs at Uppsala University. “It will soon be available in clinics”, says Christel Bergström, who is heading the project.
-
Ökade vinster för privata vårdbolag – men allvarlig rekryteringskris hotar
Rejält ökad omsättning och den bästa lönsamheten på fem år. Det går bra ekonomiskt nu för den privata vården och omsorgen – men runt hörnet lurar utmaningar i form av bland annat personalbrist.
-
Spermosens tar in 24 miljoner – ska lansera ny diagnostik inför IVF
“En banbrytande produkt som kan hjälpa miljontals drabbade av ofrivillig barnlöshet”. Så beskriver bolaget Spermosens en ny mätmetod för män som företaget uppger ger bättre chans vid IVF-behandling.
-
Neanderthal genes and Nobel Prize in a popular lecture at Bioscience
An inherited gene variant from our ”evolutionary cousins” – the extinct Neanderthals – may affect how our bodies break down certain drugs. “It’s only a matter of time before we actively start screening for it,” said KI researcher Hugo Zeberg when
-
"Are we doing business the wrong way around in the Life Science Sector?"
For the past 50 years we have created solutions for problems that we thought would solve the problems. Pharmaceuticals have created big block buster drugs which were great for that time but now we realise that these drugs were in fact only tested in white men and certainly not for patients who are older who are taking a number of medications.
-
Miljöpremie föreslås för läkemedelstillverkning – ska sporra till mindre utsläpp
En miljöpremie föreslås prövas för att få ner utsläppen av läkemedelsrester. "Det här förslaget är ett första steg mot att kunna väga in miljörisker vid framställning av läkemedel och aktiv substans", säger Stefan Berggren, biträdande tillsynsdirektör på Läkemedelsverket.
-
Richard Bergström blir hedersdoktor vid Uppsala universitet
Uppsala universitet har utsett fem hedersdoktorer vid den medicinska och vid den farmaceutiska fakulteten. Bland de nya hedersdoktorerna finns, förutom den nationella vaccinsamordnaren, tre forskare och en journalist.
-
Alert from the Swedish Medicines Agency: Many complications with gastric balloons
According to the Swedish Medicines Agency, an increasing number of serious complications are being reported in procedures with gastric balloons as a method for weight loss. The authority fears significant shortcomings in the information to patients both before and after the procedure.
-
“We need to build flexible operating theatres”
Flexible operating theatres, micro-sensors on surgeons to monitor their well-being and 3D images projected onto organs to be operated on. These are a few ideas that three specialist surgeons are suggesting for the operating theatre of the future.
-
Barncancerfonden värvar verksamhetschef från Ung Cancer
Emma Tonnes, tidigare generalsekreterare för Ung Cancer, har rekryterats som ny verksamhetschef på Barncancerfonden.
-
Biosimilars bring price pressure, but are they sufficiently used?
When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely expensive treatments with biological drugs. So, how well has Swedish healthcare used biosimilars? The answer partly depends on whom you ask.
-
Tunga life science-namn uppmanar M-ledaren: Inrätta särskild forskningsminister
Sverige behöver en särskild minister för högre utbildning och forskning. Det skriver 31 tunga namn inom life science-området i ett öppet brev till moderatledaren Ulf Kristersson.
-
Richard Bergström har fått nytt jobb
Sveriges vaccinsamordnare Richard Bergström har sagt upp sig. Det rapporterar Läkemedelsmarknaden, som har tagit del av ett uppsägningsmejl till socialdepartementet.
-
Bought a tablet factory – and built his own empire
In 1995, Thomas Eldered was CEO of one of Pharmacia’s factories in the Stockholm area when the Swedish pharmaceutical giant, after a takeover, decided to move its production abroad. 34-year-old Thomas was facing an imminent risk of losing his job. However, instead, it actually turned out to be the starting point for one of the biggest success stories in Swedish life science.
-
Marie Gårdmark: Potential step change – EU regulators get to play with data
A new pilot from EMA is starting in September to assess wether the analysis of 'raw data' by regulatory authorities improves the evaluation of marketing approval for new medicines. Marie Grådmark writes in a column that she is looking forward to the outcome of the pilot to hopefully then understand if “in house” analyses actually will add value.
-
Studie: Svår covid-19 ger försvagat immunförsvar i minst ett halvår
Allvarlig covid-19-sjukdom påverkar immunförsvaret negativt i minst ett halvår efter tillfrisknandet, enligt en studie från Linköpings universitet.
-
Isofol Medical: "Inte befogat bedriva nya studier i egen regi"
Efter bakslaget i augusti då varken de primära eller sekundära effektmåtten uppnåddes i Agent-studien, meddelar nu Isofol Medical att det utifrån bolagets finansiella ställning inte är befogat att bedriva nya studier i egen regi.
-
Penilla Gunther blir expert i EU:s cancerråd
Som en av 15 experter tar Penilla Gunther plats i rådet som ska arbeta för att implementera EU:s cancerstrategi i medlemsländerna.
-
Genes from Neanderthals can affect the correct drug dosage
A fifth of all Europeans carry gene variants inherited from Neanderthals, which cause certain drugs to break down more slowly. This may have implications for the drug doses they should take.
-
Lucy Robertshaw: Did you know Stockholm wants to be in top 5 in the world for Life Sciences?
Karolinska Institutet Solna Campus has certainly become the next “Kendall Square”, writes Lucy Robertshaw in a column.
-
Diagnostikbolag från Umeå kan bli Årets exportsuccé
Umeåföretaget Nordic Biomarker, som utvecklar koagulationsdiagnostik, har gått till final i Årets exportsuccé.
-
Försök med screening för lungcancer i Stockholm – kan bli nationellt program
I höst inleds en pilotstudie i Stockholm som kan vara det första steget mot ett nationell screeningprogram för lungcancer.
-
Newly discovered gene variant linked to protection against abdominal obesity
American researchers believe they have identified a rare gene mutation that protects against abdominal obesity and metabolic syndrome. The ambition is that the discovery will lead to new treatments that can help reduce the risk of type 2 diabetes and coronary artery disease.
-
BioVentureHub CEO: “Companies with a high degree of interaction achieve greater success”
For the first time since its inception, AstraZeneca’s BioVentureHub can now recruit new companies, as some of its tenants have grown significantly and are leaving the hub. This is the message from the biohub’s CEO Magnus Björsne in an interview, in which he also highlights a study that points out that companies with a high degree of interaction with other companies achieve greater success.
BREAKING